FAFGX | MIGHX | FAFGX / MIGHX | |
Total Expense Ratio | 0.40 | 0.71 | 56% |
Annual Report Gross Expense Ratio | 0.40 | 0.71 | 56% |
Fund Existence | 5 years | 20 years | - |
Gain YTD | 11.869 | 3.521 | 337% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 323B | 11.9B | 2,714% |
Annual Yield % from dividends | 0.53 | 0.22 | 242% |
Returns for 1 year | 9.54 | -3.00 | -317% |
Returns for 3 years | 60.76 | 27.32 | 222% |
Returns for 5 years | N/A | 28.89 | - |
Returns for 10 years | N/A | 78.40 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LFSC | 25.20 | 0.17 | +0.68% |
F/m Emerald Life Sciences Innovation ETF | |||
PCIG | 9.69 | 0.05 | +0.52% |
Polen Capital International Growth ETF | |||
VCRB | 76.65 | 0.13 | +0.18% |
Vanguard Core Bond ETF | |||
QMAR | 31.16 | N/A | N/A |
FT Vest Nasdaq-100 Buffer ETF – Mar | |||
GGZ | 13.33 | -0.09 | -0.67% |
Gabelli Global Small and Mid Cap Value Trust (The) |